Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial. J Am Coll Cardiol. 2007;50:291 5. 744. Hochholzer W, Trenk D, Frundi D, et al. Time dependence of platelet inhibition after a 60 mg loading dose of clopidogrel in a large, unse- lected cohort of candidates for percutaneous coronary intervention. Circulation. 2005;111:2560 4. 745. von Beckerath N., Taubert D, Pogatsa-Murray G, et al. Absorption, metabolization, and antiplatelet effects of 30 , 60 , and 90 mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intra- coronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. Circulation. 2005;112:2946 50. 746. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopi- dogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001 15. 747. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361: 1045 57. 748. Jagathesan R, Rosen SD, Foale RA, et al. Effects of long-term oral dipyridamole treatment on coronary microcirculatory function in patients with chronic stable angina: A substudy of the persantine in stable angina (PISA) study. J Cardiovasc Pharmacol. 2006;48:110 6. 749. Tsuya T, Okada M, Horie H, et al. Effect of dipyridamole at the usual oral dose on exercise-induced myocardial ischemia in stable angina pectoris. Am J Cardiol. 1990;66:275 8. 750. Byzova TV, Plow EF. Networking in the hemostatic system. Integrin alphaiibbeta3 binds prothrombin and influences its activation. J Biol Chem. 1997;272:27183 8. 751. Dahlback B. Blood coagulation. Lancet. 2000;355:1627 32. 752. Held C, Hjemdahl P, Rehnqvist N, et al. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm. Circulation. 1997;95:2380 6. 753. 